Blood vessels made through tissue engineering are being trialled in humans and may provide a future source of grafts from coronary applications. That is the latest from a California-based company, Cytograft, who presented details of their methods and current human trial at the AHA meeting. Todd McAllister told Audio Medica how it all works.
[audio:https://www.audiomedica.com/podcasting/aha2005/Todd_McAllister.mp3]
REPAIR-AMI: Progenitor Cells Regenerate the Heart after Infarction 16 Nov, 2005 Optimized Anti-Platelet Therapy Avoids Stent Thrombosis With Drug Eluting Stents: HORIZON-AMI Trial Results 31 Mar, 2009 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 13 Nov, 2006 Human Growth Hormone: Responses in Severe Heart Failure 17 Nov, 2005 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014